# Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC

> **NCT05550090** · — · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Metastatic Breast Cancer in the Liver

## Interventions

- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT05550090
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-16
- **Primary completion:** 2025-09-16
- **Final completion:** 2025-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05550090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05550090, "Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05550090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*